CSIMarket
Company Name or Ticker Symbol
Search for other Categories


Gilead Sciences Inc  (GILD)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Gilead Sciences Inc

GILD's Fundamental analysis






Gilead Sciences Inc's sales fell by -2.59 % in IV. Quarter 2018 from the same quarter a year ago. Ranking at No. 1284

Biotechnology & Drugs industry recorded growth of revenues by 2.56 %

Gilead Sciences Inc realized net income compared to net loss a year ago in IV. Quarter 2018

More on GILD's Growth


Gilead Sciences Inc
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Gilead Sciences Inc PEG ratio is at 0.86 , above Biotechnology & Drugs industry PEG average of 0.
Company
15.85
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 3.87.
Biotechnology & Drugs industry's Price to Sales ratio is at 4.9.
With annual estimated revenue growth of 33.32 % for 2015, Company's P/S ratio deteriorated to 2.9.

More on GILD's Valuation
 
 Total Debt (Millions $) 27,322
 Dividend TTM ($) 2.28 $
 Dividend Yield TTM (%) 3.44 %
 Revenue/Employee (TTM) $ 3,161,000
 Net Income/Employee (TTM) $ 780,000
 Receivable Turnover (TTM) 6.27
 Tangible Book Value (Per Share $) 1.29

Gilead Sciences Inc
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Gilead Sciences Inc PEG ratio is at 0.86 , above Biotechnology & Drugs industry PEG average of 0.
Company
15.85
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 3.87.
Biotechnology & Drugs industry's Price to Sales ratio is at 4.9.
With annual estimated revenue growth of 33.32 % for 2015, Company's P/S ratio deteriorated to 2.9.

More on GILD's Valuation

 Market Capitalization (Millions $) 85,589
 Shares Outstanding (Millions) 1,297
 Employees 7,000
 Revenues (TTM) (Millions $) 22,127
 Net Income (TTM) (Millions $) 5,460
 Cash Flow (TTM) (Millions $) 10,352
 Capital Exp. (TTM) (Millions $) -924
 Total Debt (Millions $) 27,322
 Dividend TTM ($) 2.28 $
 Dividend Yield TTM (%) 3.44 %
 Revenue/Employee (TTM) $ 3,161,000
 Net Income/Employee (TTM) $ 780,000
 Receivable Turnover Ratio (TTM) 6.27
 Tangible Book Value (Per Share $) 1.29

 Market Capitalization (Millions $) 85,589
 Shares Outstanding (Millions) 1,297
 Employees 7,000
 Revenues (TTM) (Millions $) 22,127
 Net Income (TTM) (Millions $) 5,460
 Cash Flow (TTM) (Millions $) 10,352
 Capital Exp. (TTM) (Millions $) -924

GILD's Profitability Comparisons
Gilead Sciences Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2018 to 19.74 % from 46.87 % in III. Quarter.

Gilead Sciences Inc net profit margin of 0.05 % is currently ranking no. 28 in Biotechnology & Drugs industry, ranking no. 176 in Healthcare sector and number 2200 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 5.37
  Total Debt to Equity (MRQ) 1.27
  Tangible Leverage Ratio (MRQ) 22.85
  Asset Turnover Ratio (TTM) 0.34
  Inventory Turnover Ratio (TTM) 5.75



Gilead Sciences Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2018 to 19.74 % from 46.87 % in III. Quarter.

Gilead Sciences Inc net profit margin of 0.05 % is currently ranking no. 28 in Biotechnology & Drugs industry, ranking no. 176 in Healthcare sector and number 2200 in S&P 500.

More on GILD's Key Ratios





             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SRNE's Profile

Stock Price

SRNE's Financials

Business Description

Fundamentals

Charts & Quotes

SRNE's News

Suppliers

SRNE's Competitors

Customers & Markets

Economic Indicators

SRNE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071